Elutia
ELUT | NASDAQ
$0.82
$0.00 (0.00%)
At close: Nov 16, 2026, 4:00 PM ET
$0.82
$0.00 (+0.35%)
After-hours:
Nov 16, 2026, 4:10 PM ET
+0.00%
(1D)No price chart data available for 1D timeframe.
Rating
60.5
Fundamentals Strong
Market Sentiment Neutral
Moat Narrow
Sector Rank #132/1021 (Top 13%)
Key Statistics
Market Data
Market Cap $36.45M
1D Range
0.80 0.84
52W Range
0.51 1.22
Valuation (TTM)
PE 0.75
PB 2.38
EV/EBITDA -0.23
Valuation (NTM)
Forward PE N/A
Forward PEG 0.02
Price Target $10.00
Cash Flow
FCF Yield -124.8%
SBC Adj. FCF Yield -137.7%
SBC Impact -10.3%
Margins
Gross Margin 59.0%
Operating Margin -262.2%
FCF Margin -457.1%
Growth (CAGR)
Revenue 3Y | 5Y -31.9% |
-2.8%
Dil EPS 3Y | 5Y 220.0% |
59.2%
FCF 3Y | 5Y -34.8% |
-24.3%
Returns
ROA 112.9%
ROE 267.7%
ROIC -81.1%
Financial Health
Net Cash
$29.09M
Current Ratio 2.63
Interest Coverage 7.53
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women’...
Sector Healthcare
Industry Biotechnology
Employees 26
IPO Date Oct 7, 2020
Website elutia.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 5, 2026
EPS
-$0.04
Beat +73.33%
YoY:
-300.00% REV
$1.14M
Beat +13.70%
YoY:
-65.78%Next Earnings
Mar 3, 2027
EPS Est
Pro
Rev Est
Pro
Add to Watchlist
Select watchlists to add or remove ELUT